These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1592175

  • 1. Determining the optimum residual moisture in lyophilized protein pharmaceuticals.
    Hsu CC, Ward CA, Pearlman R, Nguyen HM, Yeung DA, Curley JG.
    Dev Biol Stand; 1992; 74():255-70; discussion 271. PubMed ID: 1592175
    [Abstract] [Full Text] [Related]

  • 2. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.
    Pikal MJ, Dellerman K, Roy ML.
    Dev Biol Stand; 1992; 74():21-37; discussion 37-8. PubMed ID: 1592171
    [Abstract] [Full Text] [Related]

  • 3. Lyophilization cycle development for interleukin-2.
    Vemuri S.
    Dev Biol Stand; 1992; 74():341-51. PubMed ID: 1592183
    [Abstract] [Full Text] [Related]

  • 4. Moisture transfer from stopper to product and resulting stability implications.
    Pikal MJ, Shah S.
    Dev Biol Stand; 1992; 74():165-77; discussion 177-9. PubMed ID: 1592166
    [Abstract] [Full Text] [Related]

  • 5. Physical factors affecting the storage stability of freeze-dried interleukin-1 receptor antagonist: glass transition and protein conformation.
    Chang BS, Beauvais RM, Dong A, Carpenter JF.
    Arch Biochem Biophys; 1996 Jul 15; 331(2):249-58. PubMed ID: 8660705
    [Abstract] [Full Text] [Related]

  • 6. The effects of stopper drying on moisture levels of Haemophilus influenzae conjugate vaccine.
    Earle JP, Bennett PS, Larson KA, Shaw R.
    Dev Biol Stand; 1992 Jul 15; 74():203-10. PubMed ID: 1592170
    [Abstract] [Full Text] [Related]

  • 7. Stability of lyophilized human growth hormone.
    Salnikova MS, Middaugh CR, Rytting JH.
    Int J Pharm; 2008 Jun 24; 358(1-2):108-13. PubMed ID: 18394830
    [Abstract] [Full Text] [Related]

  • 8. The effect of residual moisture in lyophilized smallpox vaccine on its stability at different temperatures.
    Sparkes JD, Fenje P.
    Bull World Health Organ; 1972 Jun 24; 46(6):729-34. PubMed ID: 4538534
    [Abstract] [Full Text] [Related]

  • 9. Measurement of final container residual moisture in freeze-dried biological products.
    May JC, Wheeler RM, Etz N, Del Grosso A.
    Dev Biol Stand; 1992 Jun 24; 74():153-64. PubMed ID: 1592165
    [Abstract] [Full Text] [Related]

  • 10. Freeze-drying of histocompatibility typing sera.
    Perry VP, Kroener CA, Martin JL.
    Dev Biol Stand; 1976 Oct 24; 36():349-53. PubMed ID: 1030433
    [Abstract] [Full Text] [Related]

  • 11. Determination of adequate moisture content for efficient dry-heat viral inactivation in lyophilized factor VIII by loss on drying and by near infrared spectroscopy.
    Savage M, Torres J, Franks L, Masecar B, Hotta J.
    Biologicals; 1998 Jun 24; 26(2):119-24. PubMed ID: 9811517
    [Abstract] [Full Text] [Related]

  • 12. Methodology for in-process determination of residual water in freeze-dried products.
    Nail SL, Johnson W.
    Dev Biol Stand; 1992 Jun 24; 74():137-50; dicussion 150-1. PubMed ID: 1592164
    [Abstract] [Full Text] [Related]

  • 13. Haemoglobin lyophilized with sucrose: the effect of residual moisture on storage.
    Pristoupil TI, Kramlová M, Fortová H, Ulrych S.
    Haematologia (Budap); 1985 Jun 24; 18(1):45-52. PubMed ID: 3996946
    [Abstract] [Full Text] [Related]

  • 14. Moisture analysis of lyophilized allergenic extracts.
    Jewell JE, Workman R, Zeleznick LD.
    Dev Biol Stand; 1976 Oct 24; 36():181-9. PubMed ID: 1030418
    [Abstract] [Full Text] [Related]

  • 15. Quality control issues in the analysis of lyophilized proteins.
    Baffi RA, Garnick RL.
    Dev Biol Stand; 1992 Oct 24; 74():181-4. PubMed ID: 1592167
    [Abstract] [Full Text] [Related]

  • 16. Effect of stopper processing conditions on moisture content and ramifications for lyophilized products: comparison of "low" and "high" moisture uptake stoppers.
    Donovan PD, Corvari V, Burton MD, Rajagopalan N.
    PDA J Pharm Sci Technol; 2007 Oct 24; 61(1):51-8. PubMed ID: 17390704
    [Abstract] [Full Text] [Related]

  • 17. Surface denaturation at solid-void interface--a possible pathway by which opalescent particulates form during the storage of lyophilized tissue-type plasminogen activator at high temperatures.
    Hsu CC, Nguyen HM, Yeung DA, Brooks DA, Koe GS, Bewley TA, Pearlman R.
    Pharm Res; 1995 Jan 24; 12(1):69-77. PubMed ID: 7724490
    [Abstract] [Full Text] [Related]

  • 18. Methods for determining favorable conditions for freeze-drying biological reference materials.
    Barbaree JM.
    Dev Biol Stand; 1976 Oct 24; 36():335-41. PubMed ID: 1030431
    [Abstract] [Full Text] [Related]

  • 19. Stabilization of a freeze-dried recombinant streptokinase formulation without serum albumin.
    López M, González LR, Reyes N, Sotolongo J, Pujol V.
    J Clin Pharm Ther; 2004 Aug 24; 29(4):367-73. PubMed ID: 15271104
    [Abstract] [Full Text] [Related]

  • 20. Feasibility study on spray-drying protein pharmaceuticals: recombinant human growth hormone and tissue-type plasminogen activator.
    Mumenthaler M, Hsu CC, Pearlman R.
    Pharm Res; 1994 Jan 24; 11(1):12-20. PubMed ID: 8140042
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.